Oncology
treatment | |
---|---|
Price on request | |
transplantation | Price on request |
transplantation from a related donor | Price on request |
transplantation from an unrelated donor | Price on request |
Harley Street at University College Hospital is a united medical institution of HCA Healthcare UK and University College Hospital. The primary specialty of the Clinic is cancer treatment. The Hospital offers 24/7 diagnostic and treatment procedures at the highest level proved by ISO and CQC.
treatment | |
---|---|
Price on request | |
transplantation | Price on request |
transplantation from a related donor | Price on request |
transplantation from an unrelated donor | Price on request |
treatment | |
---|---|
Price on request | |
transplantation from a related donor | Price on request |
transplantation from an unrelated donor | Price on request |
treatment | |
---|---|
Price on request | |
transplantation | Price on request |
transplantation from a related donor | Price on request |
transplantation from an unrelated donor | Price on request |
Harley Street at University College Hospital provides medical care for 78 Specialties. And has the certifications by:
Blood cancer and blood disorders are the key specialties at Harley Street at University College Hospital. The Unit has JACIE Certification for (Bone m transplant) and stems cell therapy.
JACIE (Joint Accreditation Committee) is a part of the E (European Society for Blood and Marrow Transplantation) and ISCT (International Society for Cellular Therapy).The JACIE Accreditation means the procedures in the Hospital have the highest quality in the clinical, collection and lab units - this increases the guarantees for the patients.
A special approach at HS at UCH is dedicated to children's treatment. There are Departments of Pediatric Oncology, Pediatric Cardiology, Pediatric ear, nose and throat, Pediatric Gastroenterology, Pediatric Ophthalmology, Paediatric Nephrology, etc. in the Hospital.
The Hospital is an active member of the clinical trial programme in collaboration with the Sarah Cannon Research Institute (UK). It means patients in particular with thalassemia, iron deficiency anemia, blood cancer, sickle cell disease and other diseases matching the criteria for trials have more chances for innovative treatments than in other hospitals.